Ziel
"Our product, MicNo®, is a patented Zinc Oxide UV filter for use in cosmetic formulations. MicNo® are designed platelet-shaped micron particles composed of nano primary particles - developed to exploit benefits of the nano-size particles while removing adverse effects of them.
The aim of this project is to mature, in-vivo test and commercialise MicNo® onto the global markets. We had been awarded Phase I funding and we have conducted a Feasibility Study (GAN #741192) that verified the market potential. Our product is at TRL 7 and this project will enable us to bring our solution to TRL9 ready for commercialisation on the global cosmetics market valued at $454 billion with CAGR of 6%.
MicNo® has gone through in-vitro testing, toxicity tests as well as efficacy tests – they all showed superior broad-spectrum protection with up to 60% improvement vs. main competitors, improved transparency at application by 15-20%, mitigation of safety and health concerns related to nano zinc particles. As well as high area coverage/unit mass – a 40% reduction in raw materials usage for same UV protection.
Europe is the global flagship producer of cosmetics with a market valued at €77 billion and exports exceeding €33 billion. Thousands of companies are involved in manufacturing of cosmetics in Europe – utilising our UV filter in cosmetic formulations improves cosmetic and health benefits vs. current ZnO ingredients. We offer a solution for safer sun care products without endocrine-disrupting chemical UV filters and with lower production costs. Considering 150-200 million bottles of sunscreen are sold annually in EU this would translate to savings of €75 to €100 million/year. Moreover, we believe that our unique technology will encourage large sways of population to utilise more sun care products.
By completing this project we expect to generate accumulated turnover of €62 million and profit of €41 million over 5-years post-project completion and to create 70 new jobs.
"
Wissenschaftliches Gebiet
CORDIS klassifiziert Projekte mit EuroSciVoc, einer mehrsprachigen Taxonomie der Wissenschaftsbereiche, durch einen halbautomatischen Prozess, der auf Verfahren der Verarbeitung natürlicher Sprache beruht.
CORDIS klassifiziert Projekte mit EuroSciVoc, einer mehrsprachigen Taxonomie der Wissenschaftsbereiche, durch einen halbautomatischen Prozess, der auf Verfahren der Verarbeitung natürlicher Sprache beruht.
- natural scienceschemical sciencesinorganic chemistrytransition metals
- natural sciencesearth and related environmental sciencesenvironmental sciencesozone depletion
- medical and health sciencesclinical medicineoncologyskin cancermelanoma
- social scienceseconomics and businessbusiness and managementbusiness models
- social scienceseconomics and businesseconomicsproduction economics
Programm/Programme
- H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme
- H2020-EU.2.1.5. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing
- H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigenUnterauftrag
H2020-SMEINST-2-2016-2017
Finanzierungsplan
SME-2 - SME instrument phase 2Koordinator
26470 ESKISEHIR
Türkei
Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).